Hepatic Glucagon Signaling Regulates PCSK9 and LDL-Cholesterol
Stefano Spolitu(Columbia University), Lale Özcan(Columbia University Irving Medical Center)
Cited by 1
Related Papers
Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol
|Circulation Research|2019|63
Rap1 Activation Protects Against Fatty Liver and Non-Alcoholic Steatohepatitis Development
|bioRxiv (Cold Spring Harbor Laboratory)|2023|7
Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9
|Journal of Lipid Research|2024|7